Anja M. Sonsma

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Symptomatology of carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy.

Symptomatology of carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy.

Journal: Epilepsia

Published: October 30, 2020

Influence of common SCN1A promoter variants on the severity of SCN1A-related phenotypes.

Influence of common SCN1A promoter variants on the severity of SCN1A-related phenotypes.

Journal: Molecular genetics & genomic medicine

Published: November 19, 2018

Modifier genes in SCN1A-related epilepsy syndromes.

Modifier genes in SCN1A-related epilepsy syndromes.

Journal: Molecular genetics & genomic medicine

Published: November 19, 2018

A genome-wide association study of sodium levels and drug metabolism in an epilepsy cohort treated with carbamazepine and oxcarbazepine.

A genome-wide association study of sodium levels and drug metabolism in an epilepsy cohort treated with carbamazepine and oxcarbazepine.

Journal: Epilepsia open

Published: August 16, 2018

Outcomes and comorbidities of SCN1A-related seizure disorders.

Outcomes and comorbidities of SCN1A-related seizure disorders.

Journal: Epilepsy & behavior : E&B

Published: August 09, 2018

Assessment of parental mosaicism in SCN1A-related epilepsy by single-molecule molecular inversion probes and next-generation sequencing.

Assessment of parental mosaicism in SCN1A-related epilepsy by single-molecule molecular inversion probes and next-generation sequencing.

Journal: Journal of medical genetics

Published: August 08, 2018

Influence of contraindicated medication use on cognitive outcome in Dravet syndrome and age at first afebrile seizure as a clinical predictor in SCN1A-related seizure phenotypes.

Influence of contraindicated medication use on cognitive outcome in Dravet syndrome and age at first afebrile seizure as a clinical predictor in SCN1A-related seizure phenotypes.

Journal: Epilepsia

Published: April 06, 2018

Mosaicism of de novo pathogenic SCN1A variants in epilepsy is a frequent phenomenon that correlates with variable phenotypes.

Mosaicism of de novo pathogenic SCN1A variants in epilepsy is a frequent phenomenon that correlates with variable phenotypes.

Journal: Epilepsia

Published: January 16, 2018

Photosensitivity in Dravet syndrome is under-recognized and related to prognosis.

Photosensitivity in Dravet syndrome is under-recognized and related to prognosis.

Journal: Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology

Published: July 13, 2016

Seizure precipitants in Dravet syndrome: What events and activities are specifically provocative compared with other epilepsies?

Seizure precipitants in Dravet syndrome: What events and activities are specifically provocative compared with other epilepsies?

Journal: Epilepsy & behavior : E&B

Published: March 04, 2015

Effect of vaccinations on seizure risk and disease course in Dravet syndrome.

Effect of vaccinations on seizure risk and disease course in Dravet syndrome.

Journal: Neurology

Published: January 12, 2015

Burden analysis of rare microdeletions suggests a strong impact of neurodevelopmental genes in genetic generalised epilepsies.

Burden analysis of rare microdeletions suggests a strong impact of neurodevelopmental genes in genetic generalised epilepsies.

Journal: PLoS genetics

Published: December 30, 2014

Showing 1-12 of 13

Last Updated: 09/26/2026